Patients Seek Calif. MDL In Suits Over Diabetes Drugs
Diabetes patients suing Bristol-Myers Squibb Co. and AstraZeneca Pharmaceuticals LP over diabetes drugs Onglyza and Kombiglyze told the U.S. Judicial Panel on Multidistrict Litigation in Miami Thursday that coordination on discovery...To view the full article, register now.
Already a subscriber? Click here to view full article